The Centers for Medicare & Medicaid Services (CMS) announced the Transforming Maternal Health (TMaH) Model awardees on January 6, 2025. This 10-year payment model focuses on improving maternal health care for Medicaid and Childrens Health Insurance Program (CHIP) beneficiaries in 15 selected states while simultaneously lowering overall program costs.
TMaH provides funding to support each State Medicaid Agency (SMA) in creating and implementing an all-encompassing, whole-person strategy to provide pregnancy, childbirth, and postpartum care for eligible patients.
The program began on January 1, 2025, and runs until December 31, 2034.
The new payment model aims to improve outcomes and experiences for mothers and their newborns by:
Explore the new payment model’s details and how it can impact your health care organization with the following insights.
TMaH is administered through SMAs, serving as the model awardees. The SMA may designate the whole state or a sub-state region to participate in TMaH. Each selected SMA is eligible to receive up to $17 million in Cooperative Agreement funding over the course of the 10-year program.
CMS selected the following 15 states and sub-state regions to participate in TMaH:
SMAs can collaborate with Managed Care Entities (MCEs) as applicable, to create a plan for model participation. This may include collaboration around best practices and performance improvement strategies.
SMAs and MCEs may also coordinate with maternity care providers such as:
To take part in TMaH, the provider types must be recognized by their SMA.
TMaH is intended to promote a whole-person care approach that addresses physical and mental health, and social needs during pregnancy, childbirth, and postpartum periods. CMS will create and manage a learning system to help SMAs, their MCEs, and provider partners share information and insights as they prepare to meet model requirements.
TMaH aims to transform the maternal health care experience across three domains:
Key initiatives include:
Provider participants will be expected to deliver a risk assessment for perinatal depression, anxiety, tobacco use, substance use disorder, and health-related social needs, and offer referrals and follow-up care, as relevant. Providers will be encouraged to offer remote monitoring for chronic conditions such as diabetes and hypertension.
Care will be personalized through the creation of collaborative, individualized birth plans, with screening at the initial prenatal visit to identify additional support needs.
Optional efforts may include:
Connecting individuals to community resources and health workers to address social determinants of health is also encouraged.
TMaH was originally published with a health equity strategy under the Biden administration. Given the directives of the Trump administration, the strategy is likely to be renamed or removed from TMaH.
In the meantime, CMS:
TMaH has a three-year pre-implementation period, during which SMAs will receive technical assistance to address each model element and achieve readiness milestones, including planning for the implementation period. After this, SMAs execute the model activities during a seven-year implementation period.
During the implementation period, SMAs will provide infrastructure payments to participating health care providers, to support care delivery transformation and data infrastructure. Each SMA will develop a value-based alternative payment model that incentivizes providers to deliver high-quality, cost-effective maternity care services.
During Model Years (MY) 1-3 (2025-2027) SMAs will:
MY 4-10 (2028-2034), SMAs will implement a value-based alternative payment model for maternal care providers.
In MY 4, maternal care providers can receive upside-only incentive payments if they meet quality and patient safety measure goals and achieve a cost benchmark. Providers will receive Quality and Cost Performance Incentive Payments (PIP) based on the MY 4 performance. PIP amounts will be based on an aggregate quality performance score and cost performance score, weighted 80% and 20%, respectively.
The quality measures used to determine PIPs will be finalized by the end of MY 3. Proposed quality measures include:
Starting in MY 5, SMAs will begin to implement the state-specific, value-based alternative payment model, shifting away from status quo payments and the TMaH PIP that began in MY4. The value-based payment model will reward those who reduce excessive Medicaid and CHIP program expenditures.
CMS and SMAs will engage the recipients and key stakeholders in decisions related to the payment approach.
Maternal care providers located in one of the 15 selected locations should look for forthcoming information from their State Medicaid Agency, and may wish to subscribe to the agency’s or CMS' listserv.
For more insights on value-based care and other payment models, contact your firm professional.
Baker Tilly US, LLP, Baker Tilly Advisory Group, LP and Moss Adams LLP and their affiliated entities operate under an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable laws, regulations and professional standards. Baker Tilly Advisory Group, LP and its subsidiaries, and Baker Tilly US, LLP and its affiliated entities, trading as Baker Tilly, are members of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities. Baker Tilly US, LLP and Moss Adams LLP are licensed CPA firms that provide assurance services to their clients. Baker Tilly Advisory Group, LP and its subsidiary entities provide tax and consulting services to their clients and are not licensed CPA firms. ISO certification services offered through Moss Adams Certifications LLC. Investment advisory offered through either Moss Adams Wealth Advisors LLC or Baker Tilly Wealth Management, LLC.